APOB and atherosclerosis: Along with the activating of proinflammatory responses, SFAs was thought to impair the LDL-receptor activity and consequently increase the concentration of LDL-cholesterol (LDL-C), an apolipoprotein B-containing lipoprotein that can become trapped in the artery wall and ultimately implicated in the generation of atherosclerosis (77, 78).